| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd708a84f841d099bd81f8e8d72a610a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-00 |
| filingDate |
2004-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2272d316a064648b4eb7c9139dd60d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a0b7b3e740ab4de2ff26856011695b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67914fd07b16ede169d97f25871ae4e6 |
| publicationDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005009803-A1 |
| titleOfInvention |
MESO-oxygenated texaphyrin analogues |
| abstract |
The present invention provides compounds of Formula I n nits pharmaceutically acceptable salts, hydrate and prodrug forms thereof. |
| priorityDate |
2002-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |